Atlas Brown’s GSK GSK Stock Holding History

Atlas Brown’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$212K	Hold	4,053	–	–	0.06%	228
2026 Q1	$224K	Buy	+4,053	New	+$220K	0.07%	209
2022 Q3	–	Sell	-4,662	Closed	-$254K	–	171
2022 Q2	$254K	Hold	4,662	–	–	0.12%	148
2022 Q1	$254K	Hold	4,662	–	–	0.1%	160
2021 Q4	$257K	Hold	4,662	–	–	0.1%	161
2021 Q3	$223K	Hold	4,662	–	–	0.1%	167
2021 Q2	$232K	Hold	4,662	–	–	0.1%	163
2021 Q1	$208K	Sell	4,662 -20	-0.4%	-$908	0.1%	163
2020 Q4	$215K	Sell	4,682 -1,600	-25%	-$73.5K	0.11%	154
2020 Q3	$296K	Buy	6,282 +1,572	+33%	+$78.8K	0.18%	127
2020 Q2	$240K	Buy	+4,710	New	+$242K	0.15%	135
2020 Q1	–	Sell	-3,427	Closed	-$201K	–	143
2019 Q4	$201K	Buy	+3,427	New	+$191K	0.13%	148
2014 Q3	–	Sell	-3,035	Closed	-$203K	–	108
2014 Q2	$203K	Hold	3,035	–	–	0.1%	97
2014 Q1	$203K	Buy	+3,035	New	+$205K	0.11%	86

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Atlas Brown's GSK Position: Q2 2026 in Review

Atlas Brown held its GSK (GSK) position steady in Q2 2026 at 4,053 shares worth $212K. The position accounts for 0.06% of the portfolio, ranked #228.

Atlas Brown first reported a position in GSK in Q1 2014 and has held it in 14 quarters since. The position peaked at $296K in Q3 2020. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Atlas Brown held 4,053 shares of GSK worth $212K as of Q2 2026.
Atlas Brown left its GSK share count unchanged in Q2 2026.
GSK made up 0.06% of Atlas Brown's portfolio in Q2 2026, its #228 holding.
Atlas Brown first reported a position in GSK in Q1 2014 and has held it in 14 quarters since.
Atlas Brown's GSK position peaked at $296K in Q3 2020.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Atlas Brown's 13F filing for Q2 2026, filed 9 Jul 2026.